Oxford Sciences Innovation has returned to back a $30m funding round for Genomics, having previously contributed to a 2018 series B round.
Genomics, a UK-based precision healthcare spinout of University of Oxford, closed a $30m funding round yesterday backed by university venture fund Oxford Sciences Innovation (OSI).
Foresite Capital and F-Prime Capital, an investment affiliate of financial services group Fidelity, and Lansdowne Partners also participated in the round.
Founded in 2014, Genomics has developed a machine learning-powered genomic analytics platform that determines the risk of individuals for common diseases before they manifest.
Apart from delivering its population health management…
